Webinars.

Watch our latest webinars, featuring guest speakers and innovative technology. On-demand.

New Antibody Characterization Essentials from Discovery to Clinic

Tags: Antibody characterization, cell line development, De novo sequencing, HDX-MS, Monoclonal antibody, Recombinant expression, REmAb, SPR|

Webinar

Maximizing Liquid Biopsy Sensitivity through the Power of DNA-Binding Antibodies

watch now

Sign Up for the Newsletter

Discover the latest webinars.

Leveraging Polyclonal Antibody Sequencing to Get High Affinity Binders Against Tough Targets

Mingjie Xie2023-06-21T10:56:04-04:00Tags: Antibody characterization, De novo sequencing, Learning, Monoclonal antibody, Polyclonal antibody, Proteomics, REpAb, Technology|

Antibody Sequencing as a Tool to Improve Reproducibility in the Life Sciences

Mingjie Xie2023-06-21T10:55:52-04:00Tags: Antibody characterization, De novo sequencing, Learning, Monoclonal antibody, Proteomics, REmAb, Technology|

New Era in Anti-Drug Antibody Assays

Mingjie Xie2023-05-15T13:12:58-04:00Tags: Antibody characterization, Application, De novo sequencing, Learning, Monoclonal antibody, Proteomics, REmAb|

Research Insurance with De Novo Protein Sequencing

Mingjie Xie2024-04-01T15:50:35-04:00Tags: Antibody characterization, De novo sequencing, Hybridoma loss, Learning, Monoclonal antibody, Proteomics, REmAb, Technology|

Leveraging Recombinant Patient Antibodies in Therapeutic Applications

Mingjie Xie2023-06-21T10:54:56-04:00Tags: Antibody characterization, Antibody therapeutics, Application, De novo sequencing, Monoclonal antibody, Proteomics, Recombinant expression, REmAb, Technology|

Introduction to De Novo Protein Sequencing

Mingjie Xie2023-06-21T10:54:37-04:00Tags: De novo sequencing, Learning, Mass spectrometry, Proteomics, REmAb, Technology|

Antibody Characterization by Mass Spectrometry

Mingjie Xie2023-06-21T10:57:19-04:00Tags: Antibody characterization, De novo sequencing, Learning, Mass spectrometry, Monoclonal antibody, Proteomics, REmAb, Technology|

Talk to Our Scientists.

We Have Sequenced 9000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.

Talk to Our Scientists.

We Have Sequenced 9000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics

Webinars.

New Antibody Characterization Essentials from Discovery to Clinic

Webinar

Sign Up for the Newsletter

Discover the latest webinars.

Leveraging Polyclonal Antibody Sequencing to Get High Affinity Binders Against Tough Targets

Antibody Sequencing as a Tool to Improve Reproducibility in the Life Sciences

New Era in Anti-Drug Antibody Assays

Research Insurance with De Novo Protein Sequencing

Leveraging Recombinant Patient Antibodies in Therapeutic Applications

Introduction to De Novo Protein Sequencing

Antibody Characterization by Mass Spectrometry

Talk to Our Scientists.

We Have Sequenced 9000+ Antibodies and We Are Eager to Help You.

Talk to Our Scientists.

We Have Sequenced 9000+ Antibodies and We Are Eager to Help You.

Talk to our scientists. We have sequenced over 9000+ antibodies and we are eager to help you.

Services

Applications

Technology

Science

About

Services

Applications

Science

About